Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study

By K. Wachtell, H. Ibsen, M. Olsen, K. Borch-Johnsen, L. Lindholm, C. Mogensen, Bjrn Dahlf, Richard D. Devereux, G. Beevers, U. de Faire and 12 more. Annals of Internal Medicine, 2003

609 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Nephrology

View Paper: https://www.semanticscholar.org/paper/c6b8bf002bbe161e07eee4874432d18b06596e33

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. S. Laurent
2. E. Schiffrin
3. H. S. Boudier
4. B. K. Pedersen
5. B. Saltin

Citations in the corpus

• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “In addition, an increased risk has been documented for urinary protein levels lower than those defined as microalbuminuria.(181,182,185,186) 2.”
• The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “In both diabetic and nondiabetic hypertensive patients, microalbuminuria, even below the threshold values usually considered [216], has been shown to predict CV events [217–225], and continuous relationships between CV, as well as non-CV mortality and urinary albumin/creatinine ratios >3.”